AquaBounty Technologies (AQB) Stock Drops 25% After Public Offering

AquaBounty, a biotechnology company that uses technology to enhance productivity, announced the pricing of its previously announced public secondary offering of 1,680,000 shares of its common stock. In addition, the holders’ offering is to close on November 23 under some conditions. AQB stock dips 25% in the pre-market falling to the price of $2.32. AquaBounty is not participating in the offering and will not receive any proceeds from the sale of the issued shares. A registration statement relating to the public offering of shares of common stock was declared effective by the SEC on August 19, 2021.

The final prospectus supplement and accompanying prospectus for the offering may be obtained from Oppenheimer & Co., Inc., or from any of the following addresses. AquaBounty is on top in aquaculture technology that enables the production of fresh Atlantic salmon. The Company operates land-based farms that are designed to provide a sustainable environment. The company’s farms situated in Indiana state are meant to secure fish populations in the nearby area. AquaBounty is a company that uses genetically engineered salmon to raise healthy, antibiotic-free salmon. The company’s innovative approach helps minimize marine pollution and conserve the environment.

Anthony Gonzales

Biotech, Tech, and Crypto reporter Anthony Gonzales brings 3 years of experience in helping grassroots, mid-sized organizations and large institutions strengthen their management and resource generating capacities and effectively plan for the future. He is also a mentor and professional advisor to artists working in all disciplines. He is the gold medalist from St. Marco University of Science and Technology in the Bachelors of Financial Management as well.